Segall Bryant & Hamill LLC Takes Position in Azenta, Inc. (NASDAQ:AZTA)

Segall Bryant & Hamill LLC purchased a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 288,100 shares of the company's stock, valued at approximately $14,405,000. Segall Bryant & Hamill LLC owned about 0.63% of Azenta at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in AZTA. Prudential Financial Inc. boosted its stake in shares of Azenta by 164.9% during the 4th quarter. Prudential Financial Inc. now owns 45,868 shares of the company's stock worth $2,293,000 after purchasing an additional 28,553 shares during the period. LPL Financial LLC boosted its position in shares of Azenta by 31.4% during the fourth quarter. LPL Financial LLC now owns 50,342 shares of the company's stock valued at $2,590,000 after buying an additional 12,033 shares during the period. KLP Kapitalforvaltning AS purchased a new stake in shares of Azenta in the fourth quarter worth approximately $530,000. Sei Investments Co. lifted its stake in shares of Azenta by 59.0% during the 4th quarter. Sei Investments Co. now owns 152,536 shares of the company's stock worth $7,627,000 after acquiring an additional 56,590 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in Azenta by 10.8% during the 4th quarter. American Century Companies Inc. now owns 99,210 shares of the company's stock valued at $4,960,000 after acquiring an additional 9,640 shares during the period. Institutional investors own 99.08% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Evercore ISI lifted their target price on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Stephens reissued an "overweight" rating and set a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Needham & Company LLC lifted their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Finally, TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $58.75.

Remove Ads

Azenta Stock Performance

Shares of Azenta stock traded down $0.91 during trading on Friday, hitting $34.61. 687,601 shares of the company's stock were exchanged, compared to its average volume of 608,108. Azenta, Inc. has a 52-week low of $33.37 and a 52-week high of $63.58. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -11.61 and a beta of 1.52. The business has a 50-day simple moving average of $45.11 and a 200-day simple moving average of $46.27.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, equities analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.